Mini Review
Antitumor Activity of Novel Azoles on Ehrlich Ascites Carcinoma Cells in Mice
Fawiza Zakaria ELAblack1*, Usama Bahgat Elgazzar2 and Ahmed Elsehily 1
1Department of Organic chemistry, Damietta University, Egypt
2Department of Medical Biochemistry, Al-Azhar University, Egypt
Fawiza Zakaria ELAblack, Department of Organic chemistry, Faculty of Science, Damietta University, Egypt.
Received Date: February 04, 2020; Published Date: February 21, 2020
Abstract
Background: Azoles has been used traditionally for many centuries. Some impressive therapeutic qualities have been discovered.
Aim: Our study aims to investigate in vivo antitumor, and antioxidant activities of Ethanolic Azoles. Also, to study the side effects of Azoles on different organs (Liver/ Kidney).
Materials & Methods: We assessed the effect of Azoles on life span prolongation and on the levels of malondialdehyde (MDA), nitric oxide (NO), Catalase, glutathione peroxidase (GPx), Caspase-3, and Cytochrome c. Also, our study estimated their effect on Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Total Protein (T.P), Albumin (Alb), bilirubin, urea and creatinine.
Results: Azoles showed great increase in life span. Also, they showed a significant decrease in malondialdehyde and nitric oxide and an increase in catalase, glutathione peroxidase, caspase-3 activities, and cytochrome c concentration. Hence, it may be possible that Azoles decrease lipid peroxidation level due to their antioxidant effect and enhance apoptosis process. Azoles showed no side effects on liver and kidney. Also, they showed a significant protection for both liver and kidney histopathologically
Keywords: Antitumor activity; Erlich ascites carcinoma; Novel azoles; Triazole derivatives; Benzimidazole; Swiss albino mice
-
Fawiza Z E, Usama Bt E, Ahmed E. Antitumor Activity of Novel Azoles on Ehrlich Ascites Carcinoma Cells in Mice. Arch Neurol & Neurosci. 7(2): 2020. ANN.MS.ID.000656.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.